Low grade glial neoplasms (Q35016156)

5 August 2017

1 reference

title

Low grade glial neoplasms (English)

1 reference

5 August 2017

David G Walker

1

1 reference

PubMed ID

12464515

5 August 2017

Andrew H Kaye

series ordinal

2

1 reference

5 August 2017

1 January 2003

1 reference

Journal of Clinical Neuroscience

5 August 2017

1 reference

5 August 2017

10

1 reference

5 August 2017

1

1 reference

5 August 2017

1-13

1 reference

Low grade astrocytomas: controversies in management

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Grading of astrocytomas. A simple and reproducible method.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Oligodendroglioma: incidence and biological behavior in a defined population

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Clinicopathologic correlations in the oligodendroglioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

A histologic and cytologic method for the spatial definition of gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Gemistocytic astrocytomas: a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Protoplasmic astrocytoma. A clinicopathologic study of 16 tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Low grade supratentorial astrocytomas. Management and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Preoperative history and postoperative survival of supratentorial low-grade astrocytomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Statistical analysis of clinicopathological features, radiotherapy, and survival in 170 cases of oligodendroglioma

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Survival after stereotactic biopsy and irradiation of cerebral nonanaplastic, nonpilocytic astrocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Successful chemotherapy for recurrent malignant oligodendroglioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

The prognosis of primary intracerebral tumours presenting with epilepsy: the outcome of medical and surgical management

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Positron emission tomography in the detection of malignant degeneration of low-grade gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Stereotaxic biopsy and positron emission tomography correlation of cerebral gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Low-grade glial tumors in basal ganglia and thalamus: natural history and biological reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Prognostic factors for supratentorial low grade astrocytomas in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Treatment and survival of low-grade astrocytoma in adults--1977-1988

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Low-grade cerebral astrocytomas. Survival and quality of life after radiation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Radiotherapy of intracranial astrocytomas: analysis of 417 cases treated from 1960 through 1969.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Supratentorial malignant glioma: an analysis of radiation therapy in 178 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Prognostic factors in well-differentiated cerebral astrocytomas in the adult.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Oligodendrogliomas: the Mayo Clinic experience

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

1 reference

7 January 2021

Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Mixed oligoastrocytomas: a survival and prognostic factor analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Ganglioglioma: a correlative clinicopathological and radiological study of ten surgically treated cases with follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Age-dependent rate of anaplastic transformation in low-grade astrocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Supratentorial low-grade astrocytomas in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Prognostic implications of p53 overexpression in supratentorial astrocytic tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group stud

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Low-grade pure and mixed cerebral astrocytomas treated in the CT scan era.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Supratentorial World Health Organization Grade 2 astrocytomas and oligoastrocytomas. A new pattern of prognostic factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Proliferative potential and prognostic evaluation of low-grade astrocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Prognostic relevance of cell proliferation markers and DNA-ploidy in gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Proliferative activity and prognosis of low-grade astrocytomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Subsets of glioblastoma multiforme defined by molecular genetic analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Hyperfractionated radiation therapy for incompletely resected supratentorial low-grade glioma. A phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Clonal expansion of p53 mutant cells is associated with brain tumour progression

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Supratentorial recurrences of gliomas. Morphological studies in relation to time intervals with astrocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

The management of histologically unverified presumed cerebral gliomas with radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Suspected low-grade glioma: is deferring treatment safe?

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Morbidity and mortality of craniotomy for excision of supratentorial gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Complications of first craniotomy for intra-axial brain tumour

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

The role of surgery in low grade gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Effect of age on treatment decisions in low-grade glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

The role of stereotactic biopsy in the management of gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Usefulness of motor functional MRI correlated to cortical mapping in Rolandic low-grade astrocytomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Low grade gliomas: functional mapping resection strategies, extent of resection, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

A comparison between preoperative magnetic resonance and intraoperative ultrasound tumor volumes and margins.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Volumetric stereotactic surgical resection of intra-axial brain mass lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Results and complications from the use of a frameless stereotactic microscopic navigator system

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

The impact of technical adjuncts in the surgical management of cerebral hemispheric low-grade gliomas of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Low-grade gliomas in children: tumor volume response to radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Low-grade gliomas associated with intractable epilepsy: seizure outcome utilizing electrocorticography during tumor resection.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Radiation therapy in the management of low-grade supratentorial astrocytomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

The value of radiation therapy in addition to surgery for astrocytomas of the adult cerebrum

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

The role of radiation therapy in the treatment of astrocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Low-grade astrocytomas: treatment results and prognostic variables

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Low grade glioma of the cerebral hemispheres in adults: a retrospective analysis of 88 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Radiation therapy in the treatment of cerebral astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Neuropsychometric evaluation of long-term survivors of adult brain tumours: relationship with tumour and treatment parameters.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Development of anaplastic changes in low-grade astrocytomas of childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Low-grade astrocytomas: treatment with unconventionally fractionated external beam stereotactic radiation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Reirradiation for recurrent cerebral astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Effects of treatment on long-term survivors with malignant astrocytomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Preliminary results from a Phase II trail of conformal radiation therapy for pediatric patients with localised low-grade astrocytoma and ependymoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Three-dimensional conformal radiation treatment planning and delivery for low- and intermediate-grade gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Combined intra-arterial chemotherapy followed by radiation in astrocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Craniotomy under local anesthesia and monitored conscious sedation for the resection of tumors involving eloquent cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Awake craniotomy for aggressive resection of primary gliomas located in eloquent brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Pleomorphic xanthoastrocytoma: A distinctive meningocerebral glioma of young subjects with relatively favorable prognosisA study of 12 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Immunophenotype of pleomorphic xanthoastrocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Pleomorphic xanthoastrocytoma: what do we really know about it?

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Pleomorphic xanthoastrocytoma in the spinal cord. Case report

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Cerebellar pleomorphic xanthoastrocytoma: case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Cerebellar pleomorphic xanthoastrocytoma in an infant

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Pleomorphic xanthoastrocytoma of the retina.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Composite pleomorphic xanthoastrocytoma and ganglioglioma: report of four cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Histopathological features of recurrent pleomorphic xanthoastrocytomas: further corroboration of the glial nature of this neoplasm. A study of 3 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Pleomorphic xanthoastrocytoma. Ultrastructural and immunohistochemical study of a case with a rapidly fatal outcome following surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Pleomorphic xanthoastrocytoma. Report of four cases

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Pleomorphic xanthoastrocytoma: CT appearance

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

The pleomorphic xanthoastrocytoma and its differential diagnosis: A study of five cases

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Pleomorphic xanthoastrocytoma with CT and MRI appearance of meningioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Subependymal giant cell astrocytoma: clinical and neuroimaging features of four cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Gadolinium-DTPA enhanced MR imaging in tuberous sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Sequential CT study of subependymal giant-cell astrocytoma associated with tuberous sclerosis. Case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Tuberous sclerosis: a review for the neurosurgeon

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Subependymal giant-cell astrocytoma in children. An unusual discrepancy between histological and clinical features.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Rapid regrowth of solitary subependymal giant cell astrocytoma--case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Early diagnosis of subependymal giant cell astrocytoma in patients with tuberous sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Connatal brain tumors in patients with tuberous sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Oligodendrogliomas. I. A clinical study of cerebral oligodendrogliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

High-grade pediatric spinal cord tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Oligodendroglioma of the "widespread" type in the spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Oligodendroglioma. A comparison of two grading systems

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Prognostic relevance of DNA flow cytometry in oligodendroglioma

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Oligodendroglioma. Histologic evaluation and prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Grading of oligodendrogliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Oligodendroglioma: an analysis of 42 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Proliferating cell nuclear antigen and Ki-67 immunohistochemistry of oligodendrogliomas with special reference to prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Expression of p53 in oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

p53 immunoreactivity in oligodendrogliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Factors possibly influencing the prognosis of oligodendroglioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Role of radiation therapy in the treatment of cerebral oligodendroglioma: an analysis of 57 cases and a literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Treatment of oligodendrogliomas with or without postoperative irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Management of oligodendrogliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Aggressive oligodendroglioma: a chemosensitive tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Future directions for temozolomide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Spinal cord ganglioglioma presenting as hydrocephalus

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Central nervous system gangliogliomas. Part 2: Clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Coexistence of neoplasia and cortical dysplasia in patients presenting with seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Ganglioglioma: a detailed histopathological and immunohistochemical analysis of 61 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

A clinicopathologic and immunomorphologic study of 13 cases of ganglioglioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Gangliogliomas: experience with 34 patients and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Prognostic factors in supratentorial ganglioglioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Development of ganglioglioma in computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Gangliogliomas: clinical, radiological, and histopathological findings in 51 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

Ganglioglioma: a clinical study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2802%2900261-8

7 January 2021

10.1016/S0967-5868(02)00261-8

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12464515